» Articles » PMID: 12463036

[Hepatitis B Virus Infection: a Public Health Problem in Madagascar]

Overview
Date 2002 Dec 5
PMID 12463036
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

In this article, the authors summarize studies on hepatitis B virus infection in Madagascar. Estimated prevalence rate for acute or chronic HBs antigen infection is 23% among general population which classify the country in high endemicity area. Vertical and horizontal transmissions for the childhood are high with an estimated prevalence rate for HBs antigen infection of 10 to 35% among children under less than 5-year-old according to areas. This situation indicates that an expanded program of immunization against hepatitis B virus is warranted.

Citing Articles

Effectiveness and Safety of Low Dose of Tenofovir Disoproxil Fumarate in Malagasy Patients with Chronic Hepatitis B.

Razafindrazoto C, Rabenjanahary T, Rakotozafindrabe A, Rakotondrasoa S, Randriamifidy N, Rasolonjatovo A Biomed Res Int. 2022; 2022:1654620.

PMID: 35686236 PMC: 9173890. DOI: 10.1155/2022/1654620.


Origin and evolutionary dynamics of Hepatitis B virus (HBV) genotype E in Madagascar.

Lo Presti A, Andriamandimby S, Lai A, Angeletti S, Cella E, Mottini G Pathog Glob Health. 2017; 111(1):23-30.

PMID: 28081689 PMC: 5375611. DOI: 10.1080/20477724.2016.1278103.


The seroprevalence of hepatitis B surface antigen among first time blood donors in Antananarivo (Madagascar) from 2003 to 2009.

Arivelo R, Hendrison R, Elie R, Tantely R, Ramamonjisoa A, Barnia R Blood Transfus. 2011; 9(4):475-7.

PMID: 21839012 PMC: 3200422. DOI: 10.2450/2011.0102-10.